Asprosin activates multiple placental pathways in vitro : Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways
Molecular Medicine Reports · 2025
DOI: 10.3892/mmr.2025.13674 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Sophie Orton und 8 weiteren Autor:innen. Beteiligte Einrichtung: Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK. Hauptthemen laut MEDLINE: Placenta, TOR Serine-Threonine Kinases, Fibrillin-1, Wnt Signaling Pathway. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Asprosin is glucogenic adipokine that exerts a wide repertoire of actions, including the regulation of appetite, insulin resistance and cell proliferation. At present, little is known about the actions of asprosin in the human placenta. The present study investigated the effects of asprosin on the transcriptome of the BeWo and JEG‑3 placental cell lines, and assessed the expression of FBN1/Furin and asprosin's candidate receptors in healthy placentas when compared against placentas from pregnancies where the carrier had gestational diabetes mellitus (GDM). A number of methods, including tissue culture, clinical sample collection, RNA extraction, RNA sequencing, reverse transcription‑quantitative PCR and gene enrichment analyses were used in the present study. RNA sequencing revealed that asprosin induced cell specific differential expression for 51 genes in BeWo cells, and 204 in JEG‑3 cells, with nine common differentially expressed genes in both in vitro models including SLCA1 and HK2. Specific pathways involved in angiogenesis, fatty acid metabolism and mTOR/NOTCH/WNT/p53 signalling were also enriched. Only TLR4 was significantly downregulated in GDM placentas when compared with controls. The present study provides novel insight into the actions of asprosin in two well‑established in vitro placental (trophoblast) models, identifying key genes and signalling pathways. A common theme identified from these findings is that of glucose homeostasis, in accordance with the role of this adipokine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.
- College of Health and Life Sciences, Aston Medical School, Aston University, Birmingham B4 7ET, UK.
- College of Health, Medicine and Life Sciences, Brunel University of London, Uxbridge UB8 3PH, UK.
Zitieren
APA
Orton, S., Gharanei, S., Kazileviciute, J., Saravi, S., Patel, V., Chatterjee, J., Kyrou, I., Karteris, E., & Randeva, H. S. (2025). Asprosin activates multiple placental pathways in vitro : Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13674
Vancouver
Orton S, Gharanei S, Kazileviciute J, Saravi S, Patel V, Chatterjee J, et al. Asprosin activates multiple placental pathways in vitro : Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways. Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13674
BibTeX
@article{Orton2025,
author = {Orton, Sophie and Gharanei, Seley and Kazileviciute, Jovile and Saravi, Sayeh and Patel, Vanlata and Chatterjee, Jayanta and Kyrou, Ioannis and Karteris, Emmanouil and Randeva, Harpal S},
title = {Asprosin activates multiple placental pathways in vitro : Evidence for potential involvement in angiogenesis, fatty acid metabolism and the mTOR, NOTCH and WNT signalling pathways},
journal = {Molecular Medicine Reports},
year = {2025},
doi = {10.3892/mmr.2025.13674}
}
EUVIMED